Vasoactive intestinal peptide

Said S.I., Mutt V. Polypeptide with broad biological activity: Isolation from small intestine. Science 169: 1217, 1970.PubMedGoogle Scholar

Said S.I., Rosenberg R.N. Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissues. Science 192: 907, 1976.PubMedGoogle Scholar

Fahrenkrug J. VIP as a neurotransmitter in the peripheral nervous system. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 361.Google Scholar

Marley P., Emson P. VIP as a neurotransmitter in the central nervous system. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 341.Google Scholar

Said S.I. Vasoactive intestinal polypeptide (VIP): Current status. Peptides 5: 143, 1984.PubMedGoogle Scholar

Said S.I., Mutt V. Isolation from porcine intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur. J. Biochem. 28: 199, 1972.PubMedGoogle Scholar

Tatemoto K. PHI-A new brain-gut peptide. Peptides 5: 151, 1984.PubMedGoogle Scholar

Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and B-endorphin. Science 213: 1394, 1981.PubMedGoogle Scholar

Guillemin R., Brazeau P., Bohlen P., Esch F., Ling N., Wehrenberg W.B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585, 1982.PubMedGoogle Scholar

Erspamer V., Falconieri Erspamer G., Improta G., Negri L., De Castiglione R. Sauvagine, a new polypeptide from phyllomedusa sauvagei skin. Occurrence in various phyllomedusa species and pharmacological actions on rat blood pressure and diuresis. Naunyn-Schmiedebergs Arch. Pharmacol. 312: 265, 1980.PubMedGoogle Scholar

Lederis K., Letter A., McMaster D., Moore G., Schlesinger D. Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from catostomus. Science 218: 162, 1982.PubMedGoogle Scholar

Hoshino M., Yanaihara C., Hong Y.M., Kishida S., Katsumaru Y., Vandermeers A., Vandermeers-Piret M.C., Robberecht P., Christophe J., Yanaihara N. Primary structure of helodermin, a VIP-secretin-like peptide isolated from Gila monster venom. FEBS Lett. 178: 233, 1984.PubMedGoogle Scholar

Yamaguchi K., Abe K. Macromolecular forms of VIP in VIP-secreting tumors. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 469.Google Scholar

Obata K.-I., Itoh N., Okamoto H., Yanaihara C., Yanaihara N., Suzuki T. Identification and processing of biosynthetic precursors to vasoactive intestinal polypeptide in human neuroblastoma cells. FEBS Lett. 136: 123, 1981.PubMedGoogle Scholar

Itoh N., Obata K., Yanaihara N., Okamoto H. Human prepro-vasoactive intestinal polypeptide (VIP) mRNA contains the coding sequence for a novel PHI-27 like peptide, PHM-27. Nature 304: 547, 1983.PubMedGoogle Scholar

Gozes I., Bodner M., Shani Y., Fridkin M. Structure arid expression of the vasoactive intestinal peptide (VIP) gene in a human tumor. Peptides 1986, in press.Google Scholar

Bodner M., Fridkin M., Gozes I. Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome. Proc. Natl. Acad. Sci. USA 82: 3548, 1985.PubMedCentralPubMedGoogle Scholar

Mutt V. Isolation and structure of vasoactive intestinal polypeptide from various species. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 1.Google Scholar

Carlquist M., Mutt V., Jörnvall H. Isolation and characterization of bovine vasoactive intestinal peptide (VIP). FEBS Lett. 108: 457, 1979.PubMedGoogle Scholar

Dimaline R., Reeve Jr. J.R., Shively J.E., Hawke D. Isolation and characterization of rat vasoactive intestinal peptide. Peptide 5: 183, 1984.Google Scholar

Du B.-H., Eng J., Hulmes J.D., Chang M., Pan Y.-C.E., Yalow R.S. Guinea pig has a unique mammalian VIP. Biochem. Biophys. Res. Commun. 128: 1093, 1985.PubMedGoogle Scholar

Nilsson A. Structure of the vasoactive intestinal octacosapeptide from chicken intestine. The amino acid sequence. FEBS Lett. 60: 322, 1975.PubMedGoogle Scholar

Giachetti A., Said S.I., Reynolds R.C., Koniges F.C. Vasoactive intestinal polypeptide (VIP) in brain: localization in, and release from isolated nerve terminals. Proc. Natl. Acad. Sci. USA 74: 3424, 1977.PubMedCentralPubMedGoogle Scholar

Magistretti P.J., Morrison J.H., Shoemaker W.J., Sapin V., Bloom F.E. Vasoactive intestinal polypeptide induces glycogenolysis in mouse control of energy metabolism. Proc. Natl. Acad. Sci. USA 78: 6535, 1981.PubMedCentralPubMedGoogle Scholar

Johansson O., Lundberg J.M. Ultrastructural localization of VIP-like immunoreactivity in large dense-core vesicles of “cholinergic-type” nerve terminals in cat exocrine glands. Neuroscience 6: 847, 1981.PubMedGoogle Scholar

Morrison J.H., Magistretti P.J., Benoit R., Bloom F.E. The distribution and morphological characteristics of the intracortical VIP-positive cell: An immunohistochemical analysis. Brain Res. 292: 269, 1984.PubMedGoogle Scholar

Loren I., Emson P.C., Fahrenkrug J., Björklund A., Alurnents J., Håkanson R., Sundler F. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience 4: 1953, 1979.PubMedGoogle Scholar

Sims K.B., Hoffman D.L., Said S.I., Zimmerman E.A. Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: An immunocytochemical study. Brain Res. 186: 165, 1980.PubMedGoogle Scholar

Honda C.N., Rethelyi M., Petrusz P. Preferential immunohistochemical localization of vasoactive intestinal polypeptide (VIP) in the sacral spinal cord of the cat: light and electron microscopic observations. Neuroscience 3: 2183, 1983.PubMedGoogle Scholar

Hökfelt T., Schultzhberg M., Lundberg J.M., Fuxe J., Mutt V., Fahrenkrug J., Said S.I. Distribution of vasoactive intestinal polypeptide in the central and peripheral nervous systems as revealed by immunocytochemistry. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 65.Google Scholar

Lundberg J.M., Hökfelt T., Schultzberg M., Uvnäs-Wallensten K., Kohler C., Said S.I. Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: Evidence from combined immundhistochemistry and acetylcholine esterase staining. Neuroscience 4: 1539, 1979.PubMedGoogle Scholar

Edvinsson L Functional role of perivascular peptides in the control of cerebral circulation. Trends in Neurosciences 8: 126, 1985.Google Scholar

Costa M., Furness J.B. The origins, pathways and terminations of neurons with VIP-like immunoreactivity in the guinea-pig small intestine. Neuroscience 8: 665, 1983.PubMedGoogle Scholar

Weihe E., Reinecke M. Peptidergic innervation of the mammalian sinus nodes: Vasoactive intestinal polypeptide, neurotensin, substance P. Neurosci. Lett. 26: 283, 1981.PubMedGoogle Scholar

Dey R.D., Shannon W.A., Said S.I. Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats and human subjects. Cell Tissue Res. 220: 231, 1981.PubMedGoogle Scholar

Ottesen G., Larsen J.-J., Fahrenkrug J., Stjernquist M., Sundler F. Distribution and motor effect of VIP in female genital tract. Am. J. Physiol. 240: E32, 1981.PubMedGoogle Scholar

Terubayashi H., Tsuto T., Fukui K., Obata H.L., Okamura H., Fujishawa H., Itoi M., Yanaihara C., Yanaihara N., Ibata Y. VIP (Vasoactive Intestinal Peptide)-like immunoreactive amacrine cells in the retina of the rat. Exp. Eye Res. 36: 743, 1983.PubMedGoogle Scholar

Barajas L., Sokolski D.N., Lechago J. Vasoactive intestinal polypeptide-immunoreactive nerves in the kidney. Neurosci. Lett. 43: 263, 1983.PubMedGoogle Scholar

O’Dorisio M.S., O’Dorisio T.M., Cataland S., Balcerzak S.P. Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J. Lab. Clin. Med. 96: 666, 1980.PubMedGoogle Scholar

Cutz E., Chan W., Track N.S., Goth A., Said S.I. Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 275: 661, 1978.PubMedGoogle Scholar

Giachetti A., Goth A., Said S.I. Vasoactive intestinal polypeptide (VIP) in rabbit platelets and rat mast cells. Fed. Proc. 37: 657, 1978.Google Scholar

Eiden E., Eskay R.L., Scott J., Pollard H., Hotchkiss A.J. Primary cultures of bovine chromaffin cells synthesize and secrete VIP. Life Sci. 33: 687, 1983.PubMedGoogle Scholar

Makhlouf G.M., Said S.I. The effect of vasoactive intestinal peptide (VIP) on digestive and hormonal function. In: Thompson J.C. (Ed.), Gastrointestinal hormones. University of Texas Press, Austin, 1975, p. 599.Google Scholar

Schwartz C.J., Kimberg D.V., Sheerin H.E., Field M., Said S.I. Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J. Clin. Invest. 54: 536, 1974.PubMedCentralPubMedGoogle Scholar

Laburthe M., Besson J., Hui Bon Hoa D., Rosselin G. Récepteurs du, peptide intestinal vasoactif (VIP) dans les entérocytes: Liaison spécifique et stimulation de I’AMP cyclique. C.R. Acad. Sci. (Paris) 284: 2139, 1977.Google Scholar

Frandsen E.K., Moody A.J. Lipolytic action of a newly isolated vasoactive intestinal polypeptide. Horm. Metab. Res. 5: 196, 1973.PubMedGoogle Scholar

Desbuquois B., Laudat M.H., Laudat P. Vasoactive intestinal polypeptide and glucagon: Stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes. Biochem. Biophys. Res. Commun. 53: 1187, 1973.Google Scholar

Kowal J., Horst I., Pensky J., Alfonzo M. A comparison of the effects of ACTH, vasoactive intestinal peptide, and cholera toxin on adrenal cAMP and steroid synthesis. Ann. N.Y. Acad. Sci. 297: 314, 1977.PubMedGoogle Scholar

Rattan S., Said S.I., Goyal R.K. Effect of vasoactive intestinal polypeptide (VIP) on the lower esophageal sphincter pressure (LESP). Proc. Soc. Exp. Biol. Med. 155: 40, 1977.PubMedGoogle Scholar

Ryan J., Cohen G. Effect of vasoactive intestinal polypeptide (VIP) on basal and cholecystokinin-induced gallbladder-pressure. Gastroenterology 73: 870, 1977.PubMedGoogle Scholar

Phillis J.W., Kirkpatrick J.R., Said S.I. Vasoactive intestinal polypeptide excitation of central neurons. Can. J. Physiol. Pharmacol. 56: 337, 1977.Google Scholar

Quik M., Iversen L., Bloom S.R. Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. Biochem. Pharmacol. 27: 2209, 1978.PubMedGoogle Scholar

Borghi C., Nicosia S., Giachetti A., Said S.I. Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brain. Life Sci. 24: 65, 1978.Google Scholar

Said S.I. Vasodilator action of VIP: Introduction and general considerations. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 145.Google Scholar

McCulloch J., Kelly P.A.T., Uddman R., Edvinsson L. Functional role for vasoactive intestinal polypeptide in the caudate nucleus: a 2-deoxy[¹⁴C]-glucose investigation. Proc. Natl. Acad. Sci. USA 80: 1472, 1983.PubMedCentralPubMedGoogle Scholar

Riou F., Cespuglio R., Jouvet M. Proprietés hypnogenes du vasoactive intestinal polypeptide chez le rat. C.R. Acad. Sci. (Paris) 293: 679, 1981.Google Scholar

Hohmann E.L., Levine L., Tashjian A.H. Vasoactive intestinal peptide stimulates bone resorption via a cyclic adenosine 3’,5’-monophosphate dependent mechanism. Endocrinology 112: 1233, 1983.PubMedGoogle Scholar

Smitherman T.C., Sakio H., Geumei A.M., Yoshida T., Oyamada M., Said S.I. Coronary vasodilator action of VIP. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 169.Google Scholar

Ottesen B., Staun-Olsen P., Gammeltoft S., Fahrenkrug J. Receptors for vasoactive intestinal polypeptide on crude smooth muscle membranes from porcine uterus. Endocrinology 110: 2037Google Scholar

Laburthe M., Amiranoff B., Rosselin G. Peptidergic regulation of the cyclic AMP system in the intestinal epithelium. Adv. Physiol. Sci. 12: 175, 1981.Google Scholar

Robberecht P., Chatelain P., De Neef P., Camus J.-C., Waelbroeck M., Christophe J. Presence of vasoactive intestinal peptide receptors coupled to adetiylate cyclase in rat lung membranes. Biochim. Biophys. Acta 678: 76, 1981.PubMedGoogle Scholar

Kaneko T., Ctieng P.-Y., Oka H., Oda T., Yanaihara N., Yanaihara C. Vasoactive intestinal polypeptide stimulates adenylate cyclase and serotonin N-acetyltransferase activities in rat pineal in vitro. Biochem. Res. 1: 84, 1980.Google Scholar

Chatelain P., Robberecht P., Waelbroeck M., De Neef P., Camus J.-C., Huu A.N., Roba J., Christophe J. Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the hearth of five animal species. Pfluegers Arch. 397: 100, 1983.Google Scholar

Beed E.A., O’Dorisio M.S., O’Dorisio T.M., Gaginella T.S. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts. Regul. Pept. 6: 1, 1983.PubMedGoogle Scholar

Bitar K.N., Makhlouf G.M. Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide. Science 216: 531, 1982.PubMedGoogle Scholar

Dharmsathaphorn K., Harms V., Yamashiro D.J., Hughes R.J., Binder H.J., Wright E.M. Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes. J. Clin. Invest. 71: 27, 1983.PubMedCentralPubMedGoogle Scholar

Amiranoff B., Rosselin G. VIP receptors and control of cyclic AMP production. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 307.Google Scholar

Laburthe M., Bataille D., Rousset M., Besson J., Broer Y., Zweibaum A., Rosselin G. In: Nicholls P., Muller J.V., Jorgensen P.L., Moody A.J. (Eds.), Membrane protein. Pergamon Press, New York, 1978, p. 271.Google Scholar

Robberecht P., Waelbroeck M., Camus J.-C., De Neef P., Christophe J. Importance of disulfide bonds in receptors for vasoactive intestinal peptide and secretin in rat pancreatic plasma membranes. Biochem. Biophys. Acta 773: 271, 1984.PubMedGoogle Scholar

Sarrieau A., Laburthe M., Rosselin G. Intestinal VIP receptors: differential effect of trypsin on the high and low affinity binding sites. Mol. Cell. Endocrinol. 31: 301, 1973.Google Scholar

Sarrieau A., Boige N., Laburthe M. Role of phospholipids in the binding activity of vasoactive intestinal peptide receptors. Experientia 41: 631, 1985.PubMedGoogle Scholar

Paul S., Said S.I. Solubilization of active receptors for VIP from guinea pig lung. Peptides 1986, in press.Google Scholar

Laburthe M., Breant B., Rouyer-Fessard C. Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal peptide in rat intestinal epithelium by covalent cross-linking. Evidence for two classes of binding sites with different structural and functional properties. Eur. J. Biochem. 139: 181, 1984.PubMedGoogle Scholar

Muller J.-M., Luis J., Fantini J., Abadie B., Giannellini F., Marvaldi J., Pichon J. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29). Eur. J. Biochem. 151: 411, 1985.PubMedGoogle Scholar

Wood C.L., O’Dorisio M.S. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts. J. Biol. Chem. 260: 1243, 1985.PubMedGoogle Scholar

Fahrenkrug J., Galbo H., Holtz J.J., Schaffalitzky de Muckadell O.B. Influence of the autonomic nervous system on the release of vasoactive intestinal polypeptide from the porcine gastrointestinal tract. J. Physiol. 280: 405, 1978.PubMedCentralPubMedGoogle Scholar

Fahrenkrug J., Otesen B. Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics. J. Physiol. 331: 451, 1982.PubMedCentralPubMedGoogle Scholar

Anderson P.-O., Bloom S.R., Edwards V., Järhult J. Effects of stimulation of the chorda tympani in bursts on submaxillary responses in the cat. J. Physiol. 322: 469, 1982.Google Scholar

Bitar K.N., Said S.I., Weir G.C., Saffouri B., Makhlouf G.M. Neural release of vasoactive intestinal peptide from the gut. Gastroenterology 79: 1288, 1980.PubMedGoogle Scholar

Gaginella T.S., O’Dorisio T.M., Hubel K.A. Release of vasoactive intestinal polypeptide by electrical field stimulation of rabbit ileum. Regul. Pept. 2: 165, 1981.PubMedGoogle Scholar

Straus E., Keltz T.N., Yalow R.S. Enzymatic degradation of VIP. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 333.Google Scholar

Kitamura S., Ishihara Y., Said S.I. Effect of VIP, phenoxybenzamine and prednisolone on cyclic nucleotide content of isolated guinea-pig lung and trachea. Eur. J. Pharmacol. 67: 219, 1980.PubMedGoogle Scholar

Domschke S., Domschke W., Bloom S.R., Mitznegg P., Mitchell S., Lux G., Strunz U., Demling L. Pharmacokinetics and pharmacodynamics In: Bloom S.R. (Ed.), Gut hormones. Churchill Livingstone, New York, 1978, p. 475.Google Scholar

Lundberg J.M. Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Acta Physiol. Scand. (Suppl.) 496: 1, 1981.Google Scholar

Eckenstein F., Baughman R.W. Two types of cholinergic innervation in cortex, one colocalized with vasoactive intestinal polypeptide. Nature 309: 153, 1984.PubMedGoogle Scholar

Hara H., Hamill G.S., Jacobowitz D.M. Origin of cholinergic nerves to the rat major cerebral arteries: Coexistence with vasoactive intestinal polypeptide. Brain Res. Bull. 14: 179, 1985.PubMedGoogle Scholar

Pruss R.M., Moskal J.R., Eiden L.E., Beinfeld M.C. Specific regulation of vasoactive intestinal polypeptide biosynthesis by phorbol ester in bovine chromaffin cells. Endocrinology 117: 1020, 1985.PubMedGoogle Scholar

Lundberg J.M., Fahrendrug J., Larsson O., Änggård A. Corelease of vasoactive intestinal polypeptide and peptide histidine isoleucine in relation to atropine-resistant vasodilation in cat submandibular salivary gland. Neurosci. Lett. 52: 37, 1984.PubMedGoogle Scholar

Lebolenger F., Leroux P., Delarue C., Tonon M.C., Charnay Y., Dubois P.M., Coy D.H., Vaudry H. Co-localization of vasoactive intestinal peptide (VIP) and enkephalins in chromaffin cells of the adrenal gland of amphibia. Stimulation of corticosteroid production by VIP. Life Sci. 32: 375, 1983.Google Scholar

Ekblad E., Håkanson R., Sundler F. VIP and PHI coexist with and NPY-like peptide in intramural neurones of the small intestine. Regul. Pept. 10: 47, 1984.PubMedGoogle Scholar

Bataille D., Talbot J.-N., Milhaud G., Mutt V., Rosselin G. Effet du peptide intestinal vasoactif (VIP) sur la secretion de prolactin chez l’homme. C.R. Acad. Sci. (Paris) 292: 511, 1981.Google Scholar

Frawley L.S., Neill J.D. Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide. Neuroendocrinology 33: 79, 1981.PubMedGoogle Scholar

Chihara K., Iwasaki J., Minamitani N., Kaji H., Matsukura S., Tamaki N., Matsumota S., Fujita T. Effect of vasoactive intestinal polypeptide on growth hormone secretion in perfused acromegalic pituitary adenoma tissues. J. Clin. Endocrinol. Metab. 54: 733, 1982.Google Scholar

Oliva D., Nicosia S., Spada A., Giannattasio G.L VIP stimulates ACTH release and adenylate cyclase in human ACTH-secreting pituitary adenomas. Eur. J. Pharmacol. 83: 101, 1982.PubMedGoogle Scholar

Westendorf J.M., Phillips M.A., Schonbrunn A. Vasoactive intestinal peptide stimulates hormone retease from corticotropic cells in culture. Endocrinology 112: 550, 1983.PubMedGoogle Scholar

Samson W.K., Burton K.P., Reeves J.P., McCann S.M. Vasoactive intestinal peptide stimulates luteinizing hormone-releasing hormone release from median eminence synaptosomes. Regul. Pept. 2: 253, 1981.PubMedGoogle Scholar

Saffouri B., DuVal J.W., Arimura A., Makhlouf G.M. Effects of vasoactive intestinal peptide and secretin on gastrin and somatostatin secretion in the perfused rat stomach. Gastroenterology 86: 839, 1984.PubMedGoogle Scholar

Porter J.P., Saicj S.I., Ganong W.F. Vasoactive intestinal peptide stimulates renin secretion in vitro: evidence for a direct action of the peptide on the renal juxtaglomerular cells. Neuroendocrinology 36: 404, 1983.PubMedGoogle Scholar

Ganong W.F., Porter J.P., Bahnson T.D., Said S.I. Peptides and neurotransmitters that affect renin secretion. J. Hypertension 2(Suppl. 1): 75, 1984.Google Scholar

Porter J.P., Thrasher T.N., Said S.I., Ganong W.F. Vasoactive intestinal peptide in the regulation of renin secretion. Am. J. Physiol. 249: F84, 1985.PubMedGoogle Scholar

Villar H.V., Fender H.R., Rayford P.L., Ramus N.I., Thompson J.C. Inhibition of gastrin release and gastric secretion by GIP and VIP. In: Thompson J.C. (Ed.), Gastrointestinal hormones. University of Texas Press, Austin, 1975, p. 467.Google Scholar

Epelbaum J., Tapia-Arancibia L., Besson J., Rotsztejn W.H., Kordon C. Vasoactive intestinal peptide inhibits release of somatostatin from hypothalamus in vitro. Eur. J. Pharmacol. 58: 493, 1979.PubMedGoogle Scholar

Undem B.J., Dick E.C., Buckner C.K. Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung. Eur. J. Pharmacol. 88: 247, 1983.PubMedGoogle Scholar

Gespach C., Hui Bon Hoa D., Rosselin G. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophospate levels in gastric glands isolated from the guinea pig fundus or antrum. Endocrinology 112: 1597, 1983.PubMedGoogle Scholar

Said S.I. VIP overview. In: Bloom S.R. and Polak J.M. (Eds.), Gut hormones, ed. 2. Churchill Livingstone, Edinburgh, 1981, p. 379.Google Scholar

Hedlung B., Abens J., Bartfai T. Vasoactive intestinal polypeptide and muscarinic receptors: Supersensitivity induced by long-term atropine treatment. Science 220: 519, 1983.Google Scholar

Shimatsu A., Kato Y., Matsushita N., Katakami H., Yanaihara N., Imura H. Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood. Endocrinology 111: 338, 1982.PubMedGoogle Scholar

Uvnäs-Moberg K., Goiny M., Posloncec B., Blomquist L. Increased levels of VIP (vasoactive intestinal polypeptide)-like immunoreactivity in peripheral venous blood in dogs following injections of apomorphine and bromocriptine. Do dopaminergic agents induce gastric relaxation and hypotension by a release of endogenous VIP? Acta Physiol. Scand. 115: 373, 1982.PubMedGoogle Scholar

Shimatsu A., Kato Y., Matsushita N., Katakami H., Ohta H., Yanaihara N., Imura H. Effects of prostaglandin E₁ on vasoactive intestinal polypeptide release from the hypothalamus and on prolactin secretion from the pituitary in rats. Endocrinology 113: 2059, 1983.PubMedGoogle Scholar

Otten U., Lorez H.P. Nerve growth factor increases substance P, cholecystokinin and vasoactive intestinal polypeptide immunoreactivities in primary sensory neurones of newborn rats. Neurosci. Lett. 34: 153, 1983.Google Scholar

Rostene W.H., Fishchette C.T., McEwen B.S. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in the male rat brain. Abstracts of Neuroscience Meetings, 1982.Google Scholar

Lundberg J.M., Änggård A., Fahrenkrug J., Hökfelt T., Mutt V. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: Functional significance of coexisting transmitters for vasodilation and secretion. Proc. Natl. Acad. Sci. USA 77: 1651, 1980.PubMedCentralPubMedGoogle Scholar

Kawatani M., Rutigliano M., De Groat W.C. Depolarization and muscarinic excitation induced in a sympathetic ganglion by vasoactive intestinal polypeptide. Science 229: 879, 1985.PubMedGoogle Scholar

Magistretti P.J., Schorderet M. VIP and noradrenaline act synergistically to increase cyclic-AMP in cerebral cortex. Nature 308: 208, 1984.Google Scholar

Magistretti P.J., Schorderet M. Norepinephrine and histamine potentiate the increases in cyclic adenosine 3’: 5’-monophosphate elicited by vasoactive intestinal polypeptide in mouse cerebral cortical slices: mediation by a₁ -adrenergic and H₁ -histaminergic receptors. J. Neurosci. Res. 5: 362, 1985.Google Scholar

Onali P., Eva C., Olianas M.C., Schwartz J.P., Costa E. In GH₃ pituitary cells asetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion. Mol. Pharmacol. 24: 189, 1983.PubMedGoogle Scholar

Onali P., Schwartz J.P., Costa E. Inhibition of VIP-sensitive adenylate cyclase by dopamine in rat anterior pituitary. In: Segawa T. (Ed.), Molecular pharmacology of neurotransmitter receptors. Raven Press, New York, 1983, p. 199.Google Scholar

Rotsztejn W.H., Benoist L., Besson J., Beraud G., Bluet-Pajot M.T., Kordon C., Rosselin G., Duval J. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of VIP-induced prolactin release. Neuroendocrinology 31: 282, 1980.PubMedGoogle Scholar

Carter R.F., Bitar K.N., Zfass A.M., Makhlouf G.M. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat. Gastroenterology 74: 726, 1978.PubMedGoogle Scholar

Feliu J.E., Mojena M., Silverstre R.A., Monge J., Marco J. Stimulatory effect of vasoactive intestinal peptide on glycogenolysis and gluconeogenesis in isolated rat hepatocytes: antagonism by insulin. Endocrinology 112: 2120, 1983.PubMedGoogle Scholar

Bloom S.R., Edwards A.V. Vasoactive intestinal peptide in relation to atropine resistant vasodilation in the submaxillary gland of the cat. J. Physiol. 300: 41, 1980.PubMedCentralPubMedGoogle Scholar

Suzuki Y., McMaster D., Huang M., Lederis K., Rorstad O.P. Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries. J. Neurochem. 45: 890, 1985.PubMedGoogle Scholar

Lundberg J.M., Änggård A., Pernow J., Hökfelt T. Neuropeptide Y-, substance, P- and VlP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control. Cell Tissue Res. 239: 9, 1985.PubMedGoogle Scholar

Said S.I. Peptides, endothelium and pulmonary vascular reactivity. Chest 88: 207S, 1985.PubMedGoogle Scholar

Goyal R.K., Rattan S., Said S.I. VIP as a possible neuro-transmitter of non-cholinergic non-adrenergic inhibitory neurones. Nature 288: 278, 1980.Google Scholar

Grider J.R., Cable M.B., Said S.I., Makhlouf G.M. Vasoactive intestinal peptide (VIP) as neural mediator of gastric relaxation. Am. J. Physiol. 248: G73, 1985.PubMedGoogle Scholar

Grider J.R., Cable M.B., Bitar K.N., Said S.I., Makhlouf G.M. Vasoactive intestinal peptide: Relaxant neurotransmitter in tenia coli of the guinea pig. Gastroenterology 89: 36, 1985.PubMedGoogle Scholar

Matsuzaki Y., Hamasaki Y., Said S.I. Vasoactive intestinal peptide: A possible transmitter of non-adrenergic relaxation of guinea pig airways. Science 210: 1252, 1980.PubMedGoogle Scholar

Angel F., Go V.L.W., Schmalz P.F., Szurszewski J.H. Vasoactive intestinal polypeptide: A putative transmitter in the canine gastric muscularis mucosa. J. Physiol. 341: 641, 1983.PubMedCentralPubMedGoogle Scholar

Gibson A., Tucker J.F. The effects of vasoactive intestinal polypeptide and of adenosine 5’-triphosphate on the isolated anococcygeus muscle of the mouse. Br. J. Pharmacol. 77: 97, 1982.PubMedCentralPubMedGoogle Scholar

Lundberg J.M., Änggård A., Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum. Acta Physiol. Scand. 113: 329, 1981.PubMedGoogle Scholar

Nathanson I., Widdicombe J.H., Barnes P.J. Effect of vasoactive intestinal peptide on ion transport across dog tracheal epithelium. J. Appl. Physiol. 55: 1844, 1983.PubMedGoogle Scholar

Dartt D.A., Baker A.K., Vaillant C., Rose P.E. Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini. Am. J. Physiol. 247: G502, 1984.PubMedGoogle Scholar

Abe H., Engler D., Molitch M.E., Bollinger-Gruber J., Reichlin S. Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat. Endocrinology 116: 1383, 1985.PubMedGoogle Scholar

Fahrenkrug J., Emson P.C. Vasoactive intestinal polypeptide: Functional aspects. Br. Med. Bull. 38: 265, 1982.PubMedGoogle Scholar

Willis E., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol. Scand. 113: 545, 1981.PubMedGoogle Scholar

Willis E.A., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. Life Sci. 33: 383, 1983.PubMedGoogle Scholar

Rola-Pleszczynski M., Bolduc D., St.-Pierre S. The effects of vasoactive intestinal peptide on human natural killer cell function. J. Immunol. 135: 2569, 1985.PubMedGoogle Scholar

O’Dorisio M.S., Wood C.L., O’Dorisio T.M. Vasoactive intestinal peptide and neuropeptide modulation of the immune response. J. Immunol. 135: 792s, 1985.PubMedGoogle Scholar

Kane M.G., O’Dorisio T.M., Krejs G.J. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N. Engl. J. Med. 309: 1482, 1983.PubMedGoogle Scholar

Hunt S., Vaamonde C.A., Rattassi T., Berian M.G., Said S.I., Papper S. Circulating levels of vasoactive intestinal polypeptide (VIP) in liver disease. Arch. Intern. Med, 139: 994, 1979.PubMedGoogle Scholar

Modlin I.M., Bloom S.R., Mitchell S.J. Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischemia. Experientia 34: 535, 1978.PubMedGoogle Scholar

Revhaug A., Lygren I., Lundgren T.I., Andersen O.K., Burhol P.G., Giercksky K.E. Increased plasma levels of vasoactive intestinal polypeptide in pigs during endotoxinaemia. Eur. Surg. Res. 17: 75, 1985.PubMedGoogle Scholar

Tsuto T., Okamura H., Fukui K., Obata H.L., Terubayashi H., Iwai N., Majima S., Yanaihara N., Ibata Y. An immunohistochemical investigation of vasoactive intestinal polypeptide in the colon of patients with Hirschsprung’s disease. Neurosci. Lett. 34: 57, 1982.PubMedGoogle Scholar

Gridelli B., Buffa R., Salvini P., De Rai P., Uggeri F., Fiocca R., Said S.I. Lack of VIP-immunoreactive nerves in oesophageal achalasia. Ital. J. Gastroenterol. 14: 211, 1982.Google Scholar

Heinz-Erian P., Dey R.D., Said S.I. Deficient vasoactive intestinal peptide innervation in sweat glands of cystic fibrosis patients. Science 229: 1407, 1985.PubMedGoogle Scholar

Gjerris A., Rafaelsen O.J., Vendsborg P., Fahrenkrug J., Rehfeld J.F. Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders. J. Affect. Disorders 7: 325, 1984.PubMedGoogle Scholar

Wikkelsø C., Fahrenkrug J., Blomstrand C., Johansson B.B. Dementia of different etiologies: Vasoactive intestinal polypeptide in CSF. Neurology 35: 592, 1985.PubMedGoogle Scholar

Said S.I., Geumei A., Hara N. Bronchodilator effect of VIP in vivo: Protection against bronchoconstriction induced by histamine or prostaglandin F_2α. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 185.Google Scholar

Wasserman M.A., Griffin R.L., Malo P.E. Comparative in vitro tracheal-relaxant effects of porcine and hen VIP. In: Said S.I. (Ed.), Vasoactive intestinal peptide. Raven Press, New York, 1982, p. 185.Google Scholar

Hamasaki Y., Saga T., Mojarad M., Said S.I. VIP couteracts leukotriene D₄-induced contractions of guinea pig trachea, lung and pulmonary artery. Trans. Assoc. Am. Physicians 96: 406, 1983.PubMedGoogle Scholar

Diamond L., Szarek J.L., Gillespie M.N., Altiere R.J. In vivo bronchodilator activity of vasoactive intestinal peptide in the cat. Am. J. Respir. Dis. 128: 827, 1983.Google Scholar

Mojarad M., Grode T.L., Cox C.P., Kimmel G., Said S.I. Differential responses of human asthmatics to inhaled vasoactive intestinal peptide (VIP). Am. Rev. Respir. Dis. 131: 281 A, 1985.Google Scholar